ArticleAnnals of clinical microbiology and antimicrobials2025

In vitro activity of rifampicin, rifapentine and rifabutin in combination with their 25-deacetyl-metabolites against various Mycobacterium tuberculosis lineages.

Charlotte Genestet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.